Dômes Pharma has launched Bonqat and Tessie, two products designed to alleviate anxiety in cats and dogs respectively.

Bonqat 50 mg/ml oral solution for cats contains pregabalin, an analgesic, anti-epileptic which has now been licensed for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.

Tessie 0.3 mg/ml oral solution for dogs contains tasipimidine and is licensed for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.

Dômes Pharma points to research which shows that in the UK 1.4 million1 dogs show signs of distress when left alone, and 4.4 million dogs1 show fear of loud noises.

In addition, over 4 million cats2 are not having routine vet checkups each year, with 26%2 of these owners reporting that it is too stressful for their cat or themselves. 

Jonathan Hill, UK country manager at Dômes Pharma sid: "Dômes Pharma is excited to be launching two new innovative products to help vets manage cases in this complex area.

"These products expand our portfolio and provide essential options for owners and their pets struggling with these situational related problems."

https://www.tvm-uk.com/the-behavioural-range 

Reference

  1. https://www.pdsa.org.uk/media/13976/pdsa-paw-report-2023.pdf Accessed 16.10.2024
  2. Cats Report 2024 - https://www.cats.org.uk/media/hzfjahh2/cats-report-uk-2024.pdf Accessed 16.10.2024

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.